Budget Impact and Cost-Effectiveness of Including a Pentavalent Rotavirus Vaccine in the New Zealand Childhood Immunization Schedule
Authors:
- Richard J. MilneRMRichard J. Milne
- Keith GrimwoodKGKeith Grimwood
- 1 September 2009
- journal article
- Published by Elsevier in Value in Health
- Vol. 12 (6) , 888-898
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Postlicensure Monitoring of Intussusception After RotaTeq Vaccination in the United States, February 1, 2006, to September 25, 2007Pediatrics, 2008
- Costs of Community‐Acquired Pediatric Rotavirus Gastroenteritis in 7 European Countries: The REVEAL StudyThe Journal of Infectious Diseases, 2007
- Multicenter Prospective Study of the Burden of Rotavirus Acute Gastroenteritis in Europe, 2004–2005: The REVEAL StudyThe Journal of Infectious Diseases, 2007
- Hospitalizations and Deaths from Diarrhea and Rotavirus among Children <5 Years of Age in the United States, 1993–2003The Journal of Infectious Diseases, 2007
- Prevention of Rotavirus Disease: Guidelines for Use of Rotavirus VaccinePediatrics, 2007
- Nosocomial rotavirus infections: A systematic reviewThe Journal of Pediatrics, 2006
- Rotavirus Infection in EuropeThe Pediatric Infectious Disease Journal, 2006
- Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysisHealth Economics, 2004
- The costs of an outbreak—an example from a Danish day care settingVaccine, 2001
- Hospital Admissions Attributable To Rotavirus Infection In England And WalesThe Journal of Infectious Diseases, 1996